By Roshan Fernandez
Shares of Encompass Health advanced after the company increased its revenue guidance and reported first-quarter results that topped analysts' expectations.
Shares rose 11% to $112.73 on Friday, a 52-week high. The stock is up 22% year to date.
The provider of inpatient rehabilitative services on Thursday reported net income of $151.5 million, or $1.48 a share, compared with $112.5 million, or $1.10 a share, a year earlier.
Adjusting for one-time items, earnings per share were $1.37, above the $1.19 that analysts polled by FactSet were expecting.
Revenue was $1.46 billion, up from $1.32 billion during the same period last year. Analysts were expecting $1.43 billion.
The Birmingham, Ala.-based company raised its full-year guidance, and now expects revenue between $5.85 billion and $5.93 billion. Its previous guidance was between $5.8 and $5.9 billion.
Its full-year adjusted earnings per share are now expected to be between $4.85 and $5.10, the company said. The company previously had expected between $4.67 and $4.96.
Encompass Health also said it has promoted Patrick Tuer to the newly created role of chief operating officer.
Write to Roshan Fernandez at roshan.fernandez@wsj.com
(END) Dow Jones Newswires
April 25, 2025 12:57 ET (16:57 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。